Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Obama - Clinton Disaster -- Ignore unavailable to you. Want to Upgrade?

To: d[-_-]b who wrote (42390)	12/25/2010 9:04:06 AM
From: Gersh Avery	Read Replies (1) \| Respond to of 103300

I've been sidetracked from the diabetes stuff lately. The blood sugar drops are real. And yes, it depends on the strain being used. The area that I've been stuck on lately has been MS. There has been a second case reported to me where an MRI was ran and the report came back that there are no lesions detected. Neural regeneration. I guess that placebo effect is pretty strong. Oh .. I forgot .. kidney failure. Two cases where urine function starts back up again. Ten minuets after a topical application, the patients both needed to urinate. Suggestion is such a powerful thing. Odd thing .. ED .. unexpected side effect for the diabetic folks. Morning woodies.

To: d[-_-]b who wrote (42390)	12/25/2010 10:19:46 AM
From: Gersh Avery	Read Replies (1) \| Respond to of 103300

You might find this one interesting. ncbi.nlm.nih.gov Caryophylene is commonly found in cannabis. Essential oil extractions of industrial hemp may contain as much as 35% BCE. It is the compound that is responsible for the taste and smell of black pepper. It is also the active compound in oil of cloves. It has been approved by the FDA as a food additive. "Maybe even more unexpected is that oral administration of this dietary compound exerts potent anti-inflammatory effects in wild type mice but not in CB(2) receptor (Cnr2(-/-)) knockout mice. Like other CB(2) ligands also beta-caryophyllene inhibits the pathways triggered by activation of the toll-like receptor complex CD14/TLR4/MD2, which typically lead to the expression of proinflammatory cytokines (IL-1beta, IL-6; IL-8 and TNFalpha) and promotes a TH(1) immune response. " I guess this compound is a schedule 1 drug if its source is cannabis but a FDA approved food additive otherwise.